|
answer text |
<p>The following table shows information provided by the National Institute for Health
Research (NIHR) on Departmental programme research funding for myalgic encephalomyelitis
(ME), also known as chronic fatigue syndrome (CFS), over each of the last five years.
It is not possible to disaggregate funding for research into treatments specifically
but further information on this research is available through the NIHR Journals Library
at the following link:</p><p> </p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/"
target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p> </p><table><tbody><tr><td><p>Financial
Year</p></td><td><p>£</p></td></tr><tr><td><p>2013-14</p></td><td><p>561,950</p></td></tr><tr><td><p>2014-15</p></td><td><p>426,055</p></td></tr><tr><td><p>2015-16</p></td><td><p>475,676</p></td></tr><tr><td><p>2016-17</p></td><td><p>554,785</p></td></tr><tr><td><p>2017-18</p></td><td><p>464,902</p></td></tr></tbody></table><p>
</p><p>In terms of future research, the NIHR recognises that CFS/ME is a debilitating
condition and is speaking with the UK CFS/ME Research Collaborative and patient representatives
about how best to support a joined up approach to high quality research into this
complex disorder. The NIHR welcomes funding applications for research into any aspect
of human health, including CFS/ME; it is not usual practice to ring-fence funds for
particular topics or conditions. Applications are subject to peer review and judged
in open competition, with awards being made on the basis of the importance of the
topic to patients and health and care services, value for money and scientific quality.</p>
|
|